Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

Nearly a year after alarms about CAR T-cell therapies possibly causing secondary lymphomas, studies suggest that genetic predisposition—not vector integration—are likely the primary cause of these ...

Department of Oncology, VIB-KU Leuven Center for Cancer Biology, and KU Leuven, Leuven, Belgium.

Department of Medicine III – Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. *Corresponding Author: Marc Ladanyi, Department of Pathology and Laboratory Medicine, Memorial ...

Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, PR China.

Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

M. Piffoux and J. Jacquemin contributed equally to this article. O. Tredan and Y. Drouet contributed equally to this article.

Abbreviations: BLIA, basal-like immune-activated; BLIS, basal-like immune-suppressed; H&E, hematoxylin and eosin; LumB, luminal B; MES, mesenchymal. Hematoxylin and eosin–stained sections were used to ...